Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter studyBlood, 2020-12, Vol.136 (26), p.3056-3061 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020007594 ;PMID: 32814348Full text available |
2 |
Material Type: Article
|
![]() |
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND studyBlood, 2013-01, Vol.121 (3), p.537-545 [Peer Reviewed Journal]2013 American Society of Hematology ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-04-425512 ;PMID: 23169778Full text available |
3 |
Material Type: Article
|
![]() |
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuriaBlood, 2020-07, Vol.136 (1), p.36-49 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019000940 ;PMID: 32430502Full text available |
4 |
Material Type: Article
|
![]() |
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular EventsThe New England journal of medicine, 2008-04, Vol.358 (15), p.1547-1559 [Peer Reviewed Journal]Copyright © 2008 Massachusetts Medical Society. All rights reserved. ;2008 INIST-CNRS ;Copyright 2008 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0801317 ;PMID: 18378520 ;CODEN: NEJMAGFull text available |
5 |
Material Type: Article
|
![]() |
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic PurpuraThe New England journal of medicine, 2007-11, Vol.357 (22), p.2237-2247 [Peer Reviewed Journal]Copyright © 2007 Massachusetts Medical Society. All rights reserved. ;2007 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa073275 ;PMID: 18046028 ;CODEN: NEJMAGFull text available |
6 |
Material Type: Article
|
![]() |
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter studyBlood, 2019-11, Vol.134 (20), p.1708-1711 [Peer Reviewed Journal]2019 American Society of Hematology ;2019 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019001617 ;PMID: 31570488Full text available |
7 |
Material Type: Article
|
![]() |
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failureEuropean heart journal, 2013-01, Vol.34 (1), p.57-67 [Peer Reviewed Journal]ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehs196 ;PMID: 22778174Full text available |
8 |
Material Type: Article
|
![]() |
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 StudyPediatric blood & cancer, 2016-08, Vol.63 (8), p.1407-1413 [Peer Reviewed Journal]2016 Wiley Periodicals, Inc. ;ISSN: 1545-5009 ;EISSN: 1545-5017 ;DOI: 10.1002/pbc.26003 ;PMID: 27135461Full text available |
9 |
Material Type: Article
|
![]() |
Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary HypertensionClinical pharmacology and therapeutics, 2015-01, Vol.97 (1), p.88-102 [Peer Reviewed Journal]2014 American Society for Clinical Pharmacology and Therapeutics ;2014 American Society for Clinical Pharmacology and Therapeutics. ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.10 ;PMID: 25670386Full text available |
10 |
Material Type: Article
|
![]() |
Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and NephropathyThe New England journal of medicine, 2004-11, Vol.351 (19), p.1952-1961 [Peer Reviewed Journal]Copyright © 2004 Massachusetts Medical Society. All rights reserved. ;2004 INIST-CNRS ;Copyright 2004 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa042274 ;PMID: 15516696 ;CODEN: NEJMAGFull text available |
11 |
Material Type: Article
|
![]() |
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practiceInternational journal of hematology, 2017-10, Vol.106 (4), p.508-516 [Peer Reviewed Journal]The Japanese Society of Hematology 2017 ;International Journal of Hematology is a copyright of Springer, 2017. ;ISSN: 0925-5710 ;EISSN: 1865-3774 ;DOI: 10.1007/s12185-017-2275-4 ;PMID: 28667351Full text available |
12 |
Material Type: Article
|
![]() |
The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron storesBlood, 2010-07, Vol.116 (4), p.537-543 [Peer Reviewed Journal]2010 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2009-11-250308 ;PMID: 20421452Full text available |
13 |
Material Type: Article
|
![]() |
Deferasirox nephrotoxicity-the knowns and unknownsNature reviews. Nephrology, 2014-10, Vol.10 (10), p.574-586 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2014 ;ISSN: 1759-5061 ;EISSN: 1759-507X ;DOI: 10.1038/nrneph.2014.121 ;PMID: 25048549Full text available |
14 |
Material Type: Article
|
![]() |
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopeniaHaematologica (Roma), 2013-06, Vol.98 (6), p.881-887 [Peer Reviewed Journal]Copyright© Ferrata Storti Foundation 2013 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2012.074633 ;PMID: 23445876Full text available |
15 |
Material Type: Article
|
![]() |
Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled TrialsClinical and Applied Thrombosis/Hemostasis, 2017-11, Vol.23 (8), p.928-937 [Peer Reviewed Journal]The Author(s) 2016 ;The Author(s) 2016. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content ;ISSN: 1076-0296 ;EISSN: 1938-2723 ;DOI: 10.1177/1076029616663849 ;PMID: 27572890Full text available |
16 |
Material Type: Article
|
![]() |
Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control StudyJournal of clinical oncology, 2011-08, Vol.29 (22), p.3001-3007 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.35.1908 ;PMID: 21690476Full text available |
17 |
Material Type: Article
|
![]() |
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantationHaematologica (Roma), 2014-10, Vol.99 (10), p.1632-1637 [Peer Reviewed Journal]Copyright© Ferrata Storti Foundation. ;Copyright© Ferrata Storti Foundation 2014 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2014.105908 ;PMID: 24997153Full text available |
18 |
Material Type: Article
|
![]() |
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practiceEuropean journal of haematology, 2016-09, Vol.97 (3), p.297-302 [Peer Reviewed Journal]2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ;2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. ;ISSN: 0902-4441 ;EISSN: 1600-0609 ;DOI: 10.1111/ejh.12725 ;PMID: 26709028Full text available |
19 |
Material Type: Article
|
![]() |
Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trialsPloS one, 2013-12, Vol.8 (12), p.e82662 [Peer Reviewed Journal]COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Xia et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Xia et al 2013 Xia et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0082662 ;PMID: 24376563Full text available |
20 |
Material Type: Article
|
![]() |
Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140)Antimicrobial Agents and Chemotherapy, 2008-03, Vol.52 (3), p.858-865 [Peer Reviewed Journal]2008 INIST-CNRS ;Copyright © 2008 American Society for Microbiology ;Copyright © 2008, American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/aac.00821-07 ;PMID: 18070967 ;CODEN: AACHAXFull text available |